Brief: Pharmena Starts Pre-Clinical Trial To Determine Maximum Tolerable Dose Of 1-MNA In Sars-Cov-2 Infection

Pharmena SA

17/11/2020 16:22

Nov 17 (Reuters) - Pharmena SA  PHR.WA :
    * STARTS PRE-CLINICAL TRIAL TO DETERMINE MAXIMUM TOLERABLE
DOSE OF
1-MNA DRUG IN SARS-COV-2 INFECTION

Source text for Eikon:  ID:nEM7pxw7ma 
Further company coverage:  PHR.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))